痴呆症和认知能力下降:一个健康的方法
Ecler E Jaqua1, Mai-Linh N Tran1, Pedro Alvarez1
1Family Medicine Department, Loma Linda University School of Medicine, Loma Linda, CA, USA (EJ, MLT, PA, MG).
American journal of lifestyle medicine
|November 14, 2024
概括
饮食和运动等生活方式医学干预措施可以显著降低痴呆风险. 本综述强调了基于证据的认知健康和健康老龄化策略.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 神经学 神经学
背景情况:
- 痴呆症和认知衰退代表着全球不断升级的健康问题.
- 生活方式医学,包括饮食,运动,睡眠,社交联系,压力管理和戒毒,提供了潜在的缓解策略.
- 随机对照试验 (RCT) 等传统研究方法在评估长期生活方式干预效应方面存在局限性.
研究的目的:
- 通过HEALM框架评估生活方式因素对痴呆和认知衰退的影响.
- 整合各种证据来源,以全面评估生活方式干预措施.
- 为解决认知衰老的公共卫生战略提供信息.
主要方法:
- 美国生活方式医学学院 (ACLM) 和真实健康倡议 (THI) 制定了应用到生活方式医学 (HEALM) 框架的证据层次结构的发展.
- 使用证据值路径映射 (ETPM) 方法来为HEALM框架提供信息.
- 对生活方式干预对认知健康的影响的证据的审查和综合.
主要成果:
- 强有力的证据支持植物性营养,体力活动,恢复性睡眠,以及避免对认知健康有害物质.
- 社会联系显示出缓解认知衰退的潜力.
- 对于压力管理的研究结果仍然没有确定性,需要进一步调查.
结论:
- 生活方式干预对于促进认知健康和管理痴呆风险至关重要.
- 将基于证据的生活方式策略整合到公共卫生计划中,可以对抗日益增加的痴呆症负担.
- 持续的研究对于进一步阐明生活方式在认知健康和衰老中的作用至关重要.
相关概念视频
01:30Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
01:30Cognitive Development During Adulthood
58
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
58
01:26Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
98
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
98
01:29Documentation in Long-Term and Home Healthcare Setting
873
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
873